http://www.pharmiweb.com/Press Releases in the Pharmaceutical Industry. News, Jobs and Resources at PharmiWeb.comen-gb&#169; 1998 - 2010 PharmiWeb Solutions - All Rights ReservedWed, 9 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/images/logos/pweb_logo.gifhttp://www.Pharmiweb.com20http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15571<strong>NICE welcomes topic suggestions for QOF </strong><br /> The National Institute for Health and Clinical Excellence (NICE) has today (Monday 8...<br />NICEhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15571Tue, 8 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15566<strong>APCER Pharma Announces that LPC Pharma Group to Outsource Pharmacovigilance/Drug Safety to APCER</strong><br />APCER Pharma announced that L...<br />APCER Pharmahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15566Tue, 8 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15561<strong>Solianis Monitoring AG on its Way to Success - Market Entry as Planned in 2011</strong><br />ZURICH, February 8 /PRNewswire/ -- Solianis Monit...<br />Solianis Monitoring AGhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15561Tue, 8 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15560<strong>Artimplant: Year-End Report 2009 is Published on February 11 2010 at Approximately 8:45 Am (CET) with Conference Call at 11 Am (CET)</strong><...<br />Artimplanthttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15560Tue, 8 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15548<strong>AMAG Pharmaceuticals Provides Feraheme® Safety Update</strong><br /> AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company ...<br />AMAG Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15548Sun, 6 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15549<strong>EpiCept Establishes At-the-Market Public Stock Offering Program</strong><br /> Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OM...<br />EpiCept Corporationhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15549Sun, 6 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15547<strong>Academic Pharmacy Committed to Setting the Standard of Patient-centered, Team-based Care</strong><br /> American Association of Colleges of P...<br />American Association of Colleges of Pharmacy (AACP)http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15547Sun, 6 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15527<strong>Study Suggests Slide-On® EndoSheath® System Provides Several Advantages over Traditional Germicidal Immersion</strong><br /> Results of a cli...<br />Medtronic Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15527Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15518<strong>Biotrial, a key CRO player for early drug development in healthy volunteers and patients, to exhibit at two major life science conferences in ...<br />Biotrialhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15518Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15509<strong>Molecular Devices Returns to Life Sciences Marketplace</strong><br />SUNNYVALE, California, February 3 /PRNewswire/ -- Today, Molecular Device...<br />Molecular Devices Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15509Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15515<strong>Paloma Pharmaceuticals Receives Approval to Enter Phase I Clinical Trials</strong><br />JAMAICA PLAIN, Massachusetts, February 4 /PRNewswire/ ...<br />Paloma Pharmaceuticals Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15515Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15506<strong>Vantia Therapeutics&apos; Lead Candidate VA106483 Enters Phase IIb Trial for Nocturia</strong><br />SOUTHAMPTON, England, February 2 /PRNewswi...<br />Vantia Therapeuticshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15506Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15508<strong>Latest Research Reveals that Ageing is Linked to Significant Life Events and Occurs in Spurts</strong><br />LONDON, February 3 /PRNewswire/ --...<br />Q-MED Institute Q-MED UK.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15508Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15498<strong>Hypoglycemia - A Role in Criminal Behavior and a Consideration for Custodial Care</strong><br />LONDON, February 1 /PRNewswire/ -- The latest ...<br />ESP Biosciencehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15498Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15494<strong>Full Year 2009 results date notification – 19 February 2010</strong><br /> February 4, 2010 &amp;ndash; Shire plc (LSE: SHP, NASDAQ: SHPGY),...<br />Shirehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15494Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15493<strong>QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients</strong><br /> MANCHESTER, England...<br />Pfizer Inchttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15493Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15488<strong>Global SWIFT Studies Will Evaluate Safety and Efficacy of CSL Behring&apos;s Biostate(R) for von Willebrand Disease and Hemophilia A</strong><...<br />CSL Behringhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15488Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15489<strong>GSK - Pharma Boss Aims For 14% Returns On Late Stage Pipeline</strong><br />GSK - Pharma Boss Aims For 14% Returns On Late Stage PipelinePR Ne...<br />GlaxoSmithKlinehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15489Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15477<strong>Tapentadol Extended Release Data to Be Presented At American Academy of Pain Medicine Annual Meeting</strong><br /> San Antonio, TX (Februar...<br />Johnson &amp; Johnsonhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15477Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15476<strong>GSK launches new specialist unit to research and develop medicines for rare diseases</strong><br /> GSK today announces the formation of a n...<br />GlaxoSmithKlinehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15476Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15462<strong>QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients</strong><br /> Pfizer Inc. (NYSE: P...<br />Pfizer Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15462Sat, 5 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15431<strong>STELARA(TM) (ustekinumab) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis</strong><br />STELARA(TM...<br />Janssen-Cilaghttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15431Fri, 4 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15427<strong>Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)</strong><br />Shire Submits...<br />Shire Plchttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15427Fri, 4 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15378<strong>Phase Forward to Speak at Key Industry Events in February</strong><br />Phase Forward (NASDAQ: PFWD), a leading provider of data management so...<br />Phase Forwardhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15378Fri, 4 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15373<strong>Medical Research Council Technology&apos;s Centre for Therapeutics Discovery Opens its First &apos;Call For Targets&apos; in an Effort to Deve...<br />Medical Research Council Technology (MRCT)http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15373Fri, 4 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15363<strong>Noel Tracey to Head Up Gray Healthcare Recovery Team</strong><br />Noel Tracey to Head Up Gray Healthcare Recovery TeamPR NewswireLIVERPOOL, F...<br />Gray Healthcarehttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15363Fri, 4 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15292<strong>BIO-Europe Spring® 2010 to make Barcelona the hub for biotech dealmaking in March</strong><br />Leaders from the global biotechnology industry...<br />EBD Grouphttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15292Thu, 3 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15282<strong>Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) Wor...<br />Shire plchttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15282Thu, 3 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15262<strong>Pfizer Reports Fourth-Quarter and Full-Year 2009 Results; Provides 2010 Financial Guidance and 2012 Financial Targets</strong><br />Pfizer Inc...<br />Pfizer Inc.http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15262Thu, 3 Feb 2010 01:00:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15260<strong>ATLAS Biolabs GmbH Joins Roche NimbleGen’s Certified Service Provider Program for Targeted Enrichment</strong><br />Roche NimbleGen (SIX: RO, ...<br />Roche Diagnosticshttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=15260Thu, 3 Feb 2010 01:00:00 GMT